Tag: Kandu
Newly published BCI study confirms IpsiHand’s ability to improve post-stroke motor...
Kandu has announced the publication in Stroke: Vascular and Interventional Neurology of BCI-REHAB—a US National Institutes of Health (NIH)-sponsored randomised controlled trial of the company's...
BCI-enabled stroke rehabilitation therapy significantly improves functional outcomes in randomised trial
Kandu has announced results from what it describes as the first randomised controlled trial (RCT) evaluating a US Food and Drug Administration (FDA)-cleared, non-invasive...
